298 related articles for article (PubMed ID: 33429973)
1. The Growing Skyline of Advanced Hepatocellular Carcinoma Treatment: A Review.
Schipilliti FM; Garajová I; Rovesti G; Balsano R; Piacentini F; Dominici M; Gelsomino F
Pharmaceuticals (Basel); 2021 Jan; 14(1):. PubMed ID: 33429973
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era?
Nevola R; Delle Femine A; Rosato V; Kondili LA; Alfano M; Mastrocinque D; Imbriani S; Perillo P; Beccia D; Villani A; Ruocco R; Criscuolo L; La Montagna M; Russo A; Marrone A; Sasso FC; Marfella R; Rinaldi L; Esposito N; Barberis G; Claar E
Cancers (Basel); 2023 May; 15(11):. PubMed ID: 37296912
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint inhibitors for hepatocellular carcinoma - A game changer in treatment landscape.
Liu TH; Shen YC; Cheng AL
J Formos Med Assoc; 2022 Aug; 121(8):1371-1383. PubMed ID: 35400583
[TBL] [Abstract][Full Text] [Related]
4. Emerging immune checkpoint inhibitors for the treatment of hepatocellular carcinoma.
Chan LL; Chan SL
Expert Opin Emerg Drugs; 2021 Mar; 26(1):39-52. PubMed ID: 33724135
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G
World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525
[TBL] [Abstract][Full Text] [Related]
6. Systemic treatment of advanced hepatocellular cancer: new hope on the horizon.
Chang Lee R; Tebbutt N
Expert Rev Anticancer Ther; 2019 Apr; 19(4):343-353. PubMed ID: 30793991
[TBL] [Abstract][Full Text] [Related]
7. Paradigm shift in the treatment options of hepatocellular carcinoma.
Su TH; Hsu SJ; Kao JH
Liver Int; 2022 Aug; 42(9):2067-2079. PubMed ID: 34515412
[TBL] [Abstract][Full Text] [Related]
8. Emerging drugs for the treatment of hepatocellular carcinoma.
Ayoub WS; Jones PD; Yang JD; Martin P
Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
[TBL] [Abstract][Full Text] [Related]
9. Treatment of advanced hepatocellular carcinoma: immunotherapy from checkpoint blockade to potential of cellular treatment.
Siu EH; Chan AW; Chong CC; Chan SL; Lo KW; Cheung ST
Transl Gastroenterol Hepatol; 2018; 3():89. PubMed ID: 30603725
[TBL] [Abstract][Full Text] [Related]
10. Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities.
da Fonseca LG; Araujo RLC
World J Gastroenterol; 2022 Jul; 28(28):3573-3585. PubMed ID: 36161045
[TBL] [Abstract][Full Text] [Related]
11. Strategies to Improve the Antitumor Effect of Immunotherapy for Hepatocellular Carcinoma.
Xing R; Gao J; Cui Q; Wang Q
Front Immunol; 2021; 12():783236. PubMed ID: 34899747
[TBL] [Abstract][Full Text] [Related]
12. Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation.
Katariya NN; Lizaola-Mayo BC; Chascsa DM; Giorgakis E; Aqel BA; Moss AA; Uson Junior PLS; Borad MJ; Mathur AK
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565184
[TBL] [Abstract][Full Text] [Related]
13. Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review.
Reiter FP; Ben Khaled N; Ye L; Zhang C; Seidensticker M; Op den Winkel M; Denk G; Geier A; De Toni EN
Dig Dis; 2022; 40(5):565-580. PubMed ID: 34644705
[TBL] [Abstract][Full Text] [Related]
14. The Treatment Landscape of Advanced Hepatocellular Carcinoma.
Wong KM; King GG; Harris WP
Curr Oncol Rep; 2022 Jul; 24(7):917-927. PubMed ID: 35347594
[TBL] [Abstract][Full Text] [Related]
15. Challenges of advanced hepatocellular carcinoma.
Colagrande S; Inghilesi AL; Aburas S; Taliani GG; Nardi C; Marra F
World J Gastroenterol; 2016 Sep; 22(34):7645-59. PubMed ID: 27678348
[TBL] [Abstract][Full Text] [Related]
16. The Current Landscape of Clinical Trials for Systemic Treatment of HCC.
Foerster F; Galle PR
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921731
[TBL] [Abstract][Full Text] [Related]
17. Trends in the treatment of advanced hepatocellular carcinoma: immune checkpoint blockade immunotherapy and related combination therapies.
Cheng H; Sun G; Chen H; Li Y; Han Z; Li Y; Zhang P; Yang L; Li Y
Am J Cancer Res; 2019; 9(8):1536-1545. PubMed ID: 31497341
[TBL] [Abstract][Full Text] [Related]
18. Checkpoint inhibitors: literature review of new treatments for hepatocellular carcinoma.
Biglow L; Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():22. PubMed ID: 34917675
[TBL] [Abstract][Full Text] [Related]
19. Drug Treatment for Advanced Hepatocellular Carcinoma: First-Line and Beyond.
Feng MY; Chan LL; Chan SL
Curr Oncol; 2022 Aug; 29(8):5489-5507. PubMed ID: 36005172
[TBL] [Abstract][Full Text] [Related]
20. Targeted Therapy for Hepatocellular Carcinoma: Old and New Opportunities.
Laface C; Fedele P; Maselli FM; Ambrogio F; Foti C; Molinari P; Ammendola M; Lioce M; Ranieri G
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
